MicroPort CardioFlow Medtech Corporation has announced changes to its board committees effective December 15, 2025. Mr. Chen Guoming has been appointed as a member of the Audit Committee and will no longer serve on the Remuneration Committee or as chairperson of the Nomination Committee. The company has also established a Strategy Committee and a Commercialization Committee, with Mr. Chen Guoming serving as chairperson of the Commercialization Committee.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microport Cardioflow Medtech Corporation published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251215-11956341), on December 15, 2025, and is solely responsible for the information contained therein.